Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Chu

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Open Forum Infectious Diseases|December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE TrialDean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
The Journal of Infectious Diseases|June 3, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or DeathAllyson Mateja, Eric Chu, Thomas A Murray, et al.
The Journal of Infectious Diseases|August 20, 2025
Evaluating viral load sampling schemes and swabbing methods for optimal surrogacyAllyson Mateja, Eric Chu, Thomas A Murray, et al.
Open Forum Infectious Diseases|March 10, 2023
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy TrialDean Follmann, Holly E Janes, Eric Chu, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2024
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccinationMuhammad B Khalid, Ellen Zektser, Eric Chu, et al.
Nature Communications|September 11, 2024
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trialBo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Open Forum Infectious Diseases|December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE TrialDean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
The Journal of Infectious Diseases|June 3, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or DeathAllyson Mateja, Eric Chu, Thomas A Murray, et al.
The Journal of Infectious Diseases|August 20, 2025
Evaluating viral load sampling schemes and swabbing methods for optimal surrogacyAllyson Mateja, Eric Chu, Thomas A Murray, et al.
Open Forum Infectious Diseases|March 10, 2023
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy TrialDean Follmann, Holly E Janes, Eric Chu, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2024
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccinationMuhammad B Khalid, Ellen Zektser, Eric Chu, et al.
Nature Communications|September 11, 2024
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trialBo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Pageof 3